Andecaliximab [Anti-matrix Metalloproteinase-9] Induction Therapy for Ulcerative Colitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2/3 Study in Patients With Moderate to Severe Disease
安地卡利昔单抗(抗基质金属蛋白酶-9)诱导治疗溃疡性结肠炎:一项针对中重度溃疡性结肠炎患者的随机、双盲、安慰剂对照的II/III期研究
期刊:Journal of Crohns & Colitis
影响因子:8.7
doi:10.1093/ecco-jcc/jjy049
Sandborn, William J; Bhandari, Bal R; Randall, Charles; Younes, Ziad H; Romanczyk, Tomasz; Xin, Yan; Wendt, Emily; Chai, Hao; McKevitt, Matt; Zhao, Sally; Sundy, John S; Keshav, Satish; Danese, Silvio